
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? is an episode from GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD. Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Nec...
This episode belongs to GRACEcast Lung Cancer Video.
Use the player on this page to stream the episode online.
Published Jul 22, 2014, 02:27 long, audio available.